Zusammenfassung
Viele Patienten mit neurodegenerativen Erkrankungen weisen als Begleitsymptom eine Riechstörung auf. In der vorliegenden Übersicht wird die olfaktorische Funktion bei den einzelnen neurodegenerativen Krankheitsbildern beschrieben und die diagnostische Bedeutung der Riechtestung beim idiopathischen Parkinson-Syndrom und der Alzheimer-Demenz erläutert.
Abstract
Impairment of olfaction is a characteristic feature of many neurodegenerative diseases. This review summarizes the available information about olfactory function in distinct neurodegenerative conditions and indicates the advantageous use of olfactory testing in the diagnosis of Parkinson’s disease and Alzheimer’s dementia.
Literatur
Ansari KA, Johnson A (1975) Olfactory function in patients with Parkinson’s disease. J Chron Dis 28:493–497
Doty RL, Deems D, Steller S (1988) Olfactory dysfunction in Parkinson’s disease: A general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38:1237–1244
Hawkes C (2006) Olfaction in neurodegenerative disorder. Adv Otorhinolaryngol 63:133–151
Haehner A, Boesveldt S, Berendse HW et al (2009) Prevalence of smell loss in Parkinson’s disease – a multicenter study. Parkinsonism Relat Disord 15:490–494
Hummel T, Kobal G, Gudziol H, Mackay-Sim A (2007) Normative data for the „Sniffin‘ Sticks“ including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol 264:237–243
Lötsch J, Reichmann H, Hummel T (2008) Different odor tests contribute differently to the evaluation of olfactory loss. Chem Senses 33:17–21
Barz S, Hummel T, Pauli E et al (1997) Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in idiopathic Parkinson’s disease. Neurology 49:1424–1431
Welge-Lüssen A, Wattendorf E, Schwerdtfeger U, Fuhr P et al (2009) Olfactory–induced brain activity in Parkinson’s disease relates to the expression of event-related potentials: a functional magnetic resonance imaging study. Neudoscience 162(2):537–543
Tissingh G, Berendse HW, Bergmans P, DeWaard R et al (2001) Loss of olfaction in de novo and treated Parkinson’s disease: possible implications for early diagnosis. Mov Disord 16:41–46
Wattendorf E, Welge-Lüssen A, Fiedler K, Bilecen D et al (2009) Olfactory impairment predicts brain atrophy in Parkinson’s disease. Int J Neurosci 29(49):15410–15413
Hoehn MM, Yahr MD (1967) Parkinsonism. Onset, progression and mortality. Neurology 17:427–442
Haehner A, Hummel T, Hummel C, Sommer U et al (2007) Olfactory loss may be a first sign of idiopathic Parkinson’s disease. Mov Disord 22:839–842
Ponsen MM, Stoffers D, Booij J, Eck-Smit BL van et al (2004) Idiopathic hyposmia as a preclinical sign of Parkinson’s disease. Ann Neurol 56:173–181
Webster Ross G, Petrovitch H, Abbott R, Tanner CM et al (2008) Association of olfactory dysfunction with risk for future Parkinson’s disease. Ann Neurol 63:167–173
Braak H, Del Tredici K, Rub U, Vos RA de et al (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211
Witt M, Bormann K, Gudziol V, Pehlke K et al (2009) Biopsies of olfactory epithelium in patients with Parkinson’s disease. Mov Disord 24(6):906–914
Müller A, Abolmaali ND, Hakimi AR, Gloeckler T et al (2005) Olfactory bulb volumes in patients with Idiopathic Parkinson’s Disease – a pilot study. J Neural Transm 112(10):1363–1370
Scherfler C, Schocke M, Seppi K, Esterhammer R et al (2005) Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson’s disease. Brain 129:538–542
Westermann B, Wattendorf E, Schwerdtfeger U, Husner A et al (2008) Functional imaging of the cerebral olfactory system in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 79:19–24
Hummel T, Konnerth CG, Rosenheim K, Kobal G (2001) Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss. Ann Otol Rhinol Laryngol 110:976–981
Wenning GK, Shephard B, Hawkes C, Petruckevitch A et al (1995) Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand 91:247–250
Müller A, Mungersdorf M, Reichmann H, Strehle G et al (2002) Olfactory function in Parkinsonian syndromes. J Clin Neurosci 9:521–524
Suchowersky O, Reich S, Perlmutter J, Zesiewicz T et al (2006) Practice parameter: Diagnosis and prognosis of new onset Parkinson disease (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology. Neurology 66:968–975
Katzenschlager R, Lees AJ (2004) Olfaction and Parkinson’s syndromes: its role in differential diagnosis. Curr Opin Neurol 17:417–423
Verbaan D, Boesveldt S, Rooden SM van, Visser M et al (2008) Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics? Neurology 71(23):1877–1882
Silveira-Moriyama L, Guedes LC, Kingsbury A, Ayling H et al (2008) Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology 71(13):1021–1026
Katzenschlager R, Zijlmans J, Evans A, Watt H et al (2004) Olfactory function distinguishes vascular parkinsonism from Parkinson’s disease. J Neurol Neurosurg Psychiatry 75:1749–1752
Krüger S, Haehner A, Thiem C, Hummel T (2008) Neuroleptic-induced parkinsonism is associated with olfactory dysfunction. J Neurol 255:1574–1579
Müller A, Reuner U, Landis B, Kitzler H et al (2006) Extrapyramidal symptoms in Wilson‚s disease are associated with olfactory dysfunction. Mov Disord 21:1311–1316
Mesholam RI, Moberg PJ, Mahr RN, Doty RL (1998) Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer’s and Parkinson’s diseases. Arch Neurol 55:84–90
Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4):239–259
Thomann PA, Dos Santos V, Toro P et al (2009) Reduced olfactory bulb and tract volume in early Alzheimer’s disease – a MRI study. Neurobiol Aging 30(5):838–841
Eibenstein A, Fioretti AB, Simaskou MN, Sucapane P et al (2005) Olfactory screening test in mild cognitive impairment. Neurol Sci 26(3):156–160
Wilson RS, Arnold SE, Schneider JA, Boyle PA et al (2009) Olfactory impairment in presymptomatic Alzheimer’s disease. Ann N Y Acad Sci 1170:730–735
Pardini M, Huey ED, Cavanagh AL, Grafman J (2009) Olfactory function in corticobasal syndrome and frontotemporal dementia. Arch Neurol 66(1):92–96
Nordin S, Paulsen JS, Murphy C (1995) Sensory- and memory-mediated olfactory dysfunction in Huntington’s disease. J Int Neuropsychol Soc 1:281–290
Moberg PJ, Doty RL (1997) Olfactory function in Huntington’s disease patients and at-risk offspring. Int J Neurosci 89(1–2):133–139
Larsson M, Lundin A, Robin Wahlin TB (2006) Olfactory functions in asymptomatic carriers of the Huntington disease mutation. J Clin Exp Neuropsychol 28(8):1373–1380
Velázquez-Pérez L, Fernandez-Ruiz J, Díaz R, González RP et al (2006) Spinocerebellar ataxia type 2 olfactory impairment shows a pattern similar to other major neurodegenerative diseases. J Neurol 253(9):1165–1169
Fernandez-Ruiz J, Diaz R, Hall-Haro C, Vergara P et al (2003) Olfactory dysfunction in hereditary ataxia and basal ganglia disorders. Neuroreport 14:1339–1341
Connelly T, Farmer JM, Lynch DR, Doty RL (2003) Olfactory dysfunction in degenerative ataxias. J Neurol Neurosurg Psychiatry 74(10):1435–1437
Elian M (1991) Olfactory impairment in motor neuron disease: a pilot study. J Neurol Neurosurg Psychiatry 54(10):927–928
Hawkes CH, Shephard BC, Geddes JF, Body GD et al (1998) Olfactory Disorder in Motor Neuron Disease. Exp Neurol 50:248–253
Reuber M, Al-Din AS, Barborie A, Chakrabarty A (2001) New variant Creutzfeldt-Jakob disease presenting with loss of taste and smell. J Neurol Neurosurg Psychiatry 71(3):412–413
Le Pichon CE, Valley MT, Polymenidou M, Chesler AT et al (2009) Olfactory behavior and physiology are disrupted in prion protein knockout mice. Nat Neurosci 12:60–69
Hummel T, Jahnke U, Sommer U, Reichmann H et al (2005) Olfactory function in patients with idiopathic Parkinson’s disease: Effects of deep brain stimulation in the subthalamic nucleus. J Neural Transm 112:669–676
Sobel N, Thomason ME, Stappen I et al (2001) An impairment in sniffing contributes to the olfactory impairment in Parkinson’s disease. Proc Natl Acad Sci U S A 98:4154–4159
AWMF (2007) Riechstörungen – Leitlinie zur Epidemiologie, Pathophysiologie, Klassifikation, Diagnose und Therapie. AWMF online, http://www.uni-duesseldorf.de/AWMF/ll/017-050.htm
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hähner, A., Welge-Lüssen, A. Riechstörungen bei neurodegenerativen Erkrankungen. HNO 58, 644–649 (2010). https://doi.org/10.1007/s00106-010-2122-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00106-010-2122-x